Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————— FORM 8-K ————————————— Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 1, 2026 ————————————— UNITEDHEALTH GROUP INCORPORATED (Exact name of registrant as specified in its charter) ————————————— Delaware 1-10864 41-1321939 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1 Health Drive, 655 New York Avenue NW Eden Prairie, Minnesota 55344 Washington, DC 20001 (Address of principal executive offices) (Zip Code) (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 800 ) 328-5979 N/A (Former name or former address, if changed since last report.) ————————————— Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.01 par value UNH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07.      Submission of Matters to a Vote of Security Holders. On June 1, 2026, the Company held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”). There were 768,066,717 shares of common stock represented at the Annual Meeting. The shareholders of the Company voted as follows on the following matters at the Annual Meeting: 1. Election of Directors. The nine directors were elected at the Annual Meeting for a one-year term based upon the following votes: Director Nominee For Against Abstain Broker Non-Votes % of Votes For* Charles Baker 606,637,150 69,792,687 1,900,617 89,736,263 89.68% Timothy Flynn 646,534,589 31,180,999 614,866 89,736,263 95.39% Paul Garcia 657,046,651 20,686,201 597,602 89,736,263 96.94% Kristen Gil 670,734,403 7,012,293 583,758 89,736,263 98.96% Scott Gottlieb, M.D. 630,040,056 47,696,583 593,815 89,736,263 92.96% Stephen Hemsley 646,655,805 28,777,298 2,897,351 89,736,263 95.73% F. William McNabb III 658,345,360 19,413,024 572,070 89,736,263 97.13% Valerie Montgomery Rice, M.D. 660,235,862 17,561,570 533,022 89,736,263 97.40% John Noseworthy, M.D. 665,000,847 12,755,561 574,046 89,736,263 98.11% 2. Non-binding advisory vote on executive compensation. The Company’s executive compensation was approved by a non-binding advisory vote based upon the following votes: For Against Abstain Broker Non-Votes % of Votes For* 559,434,838 117,731,618 1,163,998 89,736,263 82.74% 3. Ratification of the appointment of Deloitte & Touche LLP. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified based upon the following votes: For Against Abstain % of Votes For* 729,713,547 37,552,773 800,397 95.00% 4. Shareholder proposal requesting the adoption of a policy to require any board chair to be independent. The shareholder proposal was not approved based upon the following votes: For Against Abstain Broker Non-Votes % of Votes For* 137,347,215 537,634,392 3,348,847 89,736,263 20.24% * Abstentions have no effect on the election of directors. Abstentions are counted as an Against vote for the non-binding advisory vote on executive compensation, ratification of the appointment of Deloitte & Touche LLP and shareholder proposal. Broker non-votes have no effect on the vote for any matter. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 5, 2026                  UNITEDHEALTH GROUP INCORPORATED By:  /s/ Kuai H. Leong Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary